Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis

Contraception

Volumn 81, Issue 1, 2010, Pages 88-89

  van Vliet, Huib A A M ^a   Rosendaal, Frits R ^a   Fleischer, Kathrin ^b   Rosing, Jan ^c   Helmerhorst, Frans M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PROTEIN S; SEX HORMONE BINDING GLOBULIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTICOAGULATION; COMPARATIVE STUDY; HEMOSTASIS; HUMAN; LETTER; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; RISK FACTOR; THROMBIN TIME; THROMBOSIS; TRANSDERMAL PATCH; VAGINA CONTRACEPTION; VAGINA RING;

ADMINISTRATION, CUTANEOUS; CONTRACEPTIVE DEVICES, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HEMOSTASIS; HUMANS;

EID: 71149099113     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.05.131     Document Type: Letter

References (5)

1. Jensen J.T., Burke A.E., Barnhart K.T., Tillotson C., Messerle-Forbes M., and Peters D. Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis. Contraception 78 (2008) 451-458
2. Fleischer K., van Vliet H.A.A.M., Rosendaal F.R., Rosing J., Tchaikovski S., and Helmerhorst F.M. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study. Thromb Res 123 (2009) 429-435
3. Vandenbroucke J.P., Rosing J., Bloemenkamp K.W., et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 344 (2001) 1527-1535
4. van Vliet H.A.A.M., Frolich M., Thomassen M.C.L.G.D., et al. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. Hum Reprod 20 (2005) 563-568
5. van Vliet H.A.A.M., Bertina R.M., Dahm A.E.A., et al. Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor. J Thromb Haemost 6 (2008) 346-351